Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_1
6
100%

Phase Distribution

6

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
6(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 1

Trials by Phase

Phase 16 (100.0%)

Trials by Status

terminated117%
completed583%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_1

E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck

NCT01332266
completedphase_1

A Study of E7050 Administered Orally to Patients With Advanced Solid Tumors

NCT00921869
terminatedphase_1

E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer

NCT01355302
completedphase_1

A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors

NCT00869895
completedphase_1

Pharmacokinetics and Food Effect of Single Oral Dose of E7050 in Healthy Volunteers

NCT02533102
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01332266Phase 1

E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck

Completed
NCT00921869Phase 1

A Study of E7050 Administered Orally to Patients With Advanced Solid Tumors

Completed
NCT01355302Phase 1

E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer

Terminated
NCT00869895Phase 1

A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors

Completed
NCT02533102Phase 1

Pharmacokinetics and Food Effect of Single Oral Dose of E7050 in Healthy Volunteers

Completed
NCT01428141Phase 1

A Phase I Study of E7050 in Subjects With Solid Tumors

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6